Dr. Harith Rajagopalan describes his company’s innovative procedure, Revita™ Duodenal Mucosal Resurfacing™ (DMR), and its beneficial effects on T2DM and weight.
Dr. Jens Holst discusses the hormone glucagon, including how it is affected by GLP-1 and various physiological conditions and diseases, as well as important measurement considerations.
Dr. Allison Goldfine discusses the first round of results from the exciting SLIMM-T2D study and their plan for the lapband portion of the clinical trial.
Dr. John Wahren provides intriguing insight into the use of a protein that was once thought to have no biological activity, as a way to treat diabetic complications.
Dr. Joseph Evans shares results from a recent clinical trial showing a reduction in a key mediator of atherosclerosis after supplementation with a novel dietary fiber.
Dr. Denise Faustman discusses her serendipitous and revolutionary finding about the progression of diabetes while conducting novel trials on the use of an old TB vaccine.
15 min
About Exploring Frontiers in Translational Research
From the publisher's feed
Learn about scientific advances that lead to a better understanding of diseases and therapies. Interviews with scientists and clinicians will provide you with cutting-edge information, coming directly…
from the source. Explore topics ranging from drug discovery and new FDA regulations to novel approaches to metabolic diseases (e.g., diabetes and heart disease). Hosted by Mercodia.